Sqi Diagnostics Inc (SQIDF) 0.2398 $SQIDF SQI

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Sqi Diagnostics Inc (SQIDF) 0.2398 $SQIDF

SQI Diagnostics Reports Second Quarter 2016 Results
CNW Group - Fri May 13, 7:30AM CDT
SQI Diagnostics Inc. ("SQI" or the "Company" (TSX-V: SQD; OTCQX: SQIDF), today reported its financial and operational results for the three and six months ended March 31, 2016.
SQD.VN: 0.300 (unch)

SQI Diagnostics to Announce Second Quarter 2016 Results
PR Newswire - Fri Apr 29, 7:48AM CDT
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company" (TSX-V: SQD; OTCQX: SQIDF), today announced that it plans to release its financial and operational results for the three and six months ended March 31, 2016 at 8:30am EST Friday, May 13, 2016. President and CEO, Andrew Morris, along with Company management, will host a conference call on Friday, May 13, 2016 at 10:00 a.m. ET to review financial results and discuss business developments for the period.
SQD.VN: 0.300 (unch)

Allergan to Highlight SQI Diagnostics' Technology at 10th WRIB Conference
PR Newswire - Mon Apr 18, 9:56AM CDT
SQI Diagnostics Inc. . ("SQI Diagnostics" "SQI" or the "Company" (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics today announced that its immunogenicity testing technology is being presented by Allergan at the 10th Workshop on Recent Issues in Bioanalysis in Orlando, Florida ("10th WRIB", on April 19, 2016.
AGN: 232.79 (+1.70), SQD.VN: 0.300 (unch)

SQI Sells Sqidlite(TM)-dh System to a Major Diagnostics Customer
CNW Group - Tue Mar 29, 1:59PM CDT
Major Milestone in Commercialization
SQD.VN: 0.300 (unch)

SQI Sells Sqidlite™-dh System to a Major Diagnostics Customer
PR Newswire - Tue Mar 29, 1:59PM CDT
Major Milestone in Commercialization
SQD.VN: 0.300 (unch)

SQI Diagnostics Announces Stock Option Grant
CNW Group - Wed Mar 16, 4:00PM CDT
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company" (TSX-V: SQD; OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that effective March 14, 2016, it has granted 2,054,000 stock options as part of a Company-wide long-term incentive plan. The goal of the grant is to align the interest of all employees with those of shareholders. 1,638,000 options have been granted to certain officers and directors. Independent directors did not receive options in this grant.
SQD.VN: 0.300 (unch)

SQI Diagnostics to Extend Warrant Expiry
CNW Group - Fri Mar 11, 11:07AM CST
SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics ("SQI", today announced that it intends to extend the expiry of 8,400,000 outstanding common share purchase warrants ("the Warrants" of the Company, which were issued in connection with the Company's April 2014 public offering of units of the Company. The extension of the warrants was approved by members of the Board of Directors who are independent of this series of warrants. The extension is subject to approval from the TSX Venture Exchange.
SQD.VN: 0.300 (unch)

SQI Diagnostics to Announce First Quarter 2016 Results
PR Newswire - Thu Feb 04, 8:00AM CST
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company" (TSX-V: SQD; OTCQX: SQIDF), today announced that it plans to release its financial and operational results for the three months ended December 31, 2015 at 8:30am ET Thursday, February 11, 2016. President and CEO, Andrew Morris, along with Company management, will host a conference call on Thursday February 11, 2016 at 10:00 a.m. ET to review financial results and discuss business developments for the period.
SQD.VN: 0.300 (unch)

SQI Diagnostics Reports Fourth Quarter and Fiscal 2015 Results
PR Newswire - Wed Dec 16, 4:00PM CST
Multiple Customer Agreements Position SQI for Realization of Commercial Revenues in 2016
SQD.VN: 0.300 (unch)

SQI Diagnostics to Announce Fourth Quarter and Fiscal 2015 Results
CNW Group - Thu Dec 10, 3:08PM CST
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company" (TSX-V: SQD; OTCQX: SQIDF), today announced that it plans to release its financial and operational results the fourth quarter and fiscal year ended September 30, 2015, after market close on Wednesday, December 16, 2015. President and CEO, Andrew Morris, along with Company management, will host a conference call on Thursday December 17, 2015 at 10:00 a.m. ET to review financial results and discuss business developments for the period.
SQD.VN: 0.300 (unch)

SQI Diagnostics Formalizes Multiple Contracts With Global Pharmaceutical Firm
PR Newswire - Thu Oct 22, 3:45PM CDT
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company" (TSX-V: SQD; OTCQX: SQIDF), today announced a product development agreement with a global pharmaceutical company that formalizes the terms of multiple drug initiatives over the next three years.
SQD.VN: 0.300 (unch)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trading Platforms Poised for Billions by 2031

Updated Category News Views 3

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 2

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 2

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 2

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 1

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 2

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 2

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 7

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 3

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading

Top 5 Most Recently Viewed Articles

Stablecoins Surging: Key Players and Market Impacts Explored

Updated Category News Views 92

The Rise of Stablecoins in the Financial World Stablecoins are reshaping the global financial landscape, experiencing remarkable growth and increasing importance. Recently, their supply has reached an all-time high of $170 billion, and the monthly settlement volumes now exceed $1.4 trillion as of mid-2024. Key Insights from Analysts Experts have observed that stablecoins...

Continue Reading
CoRegen, Inc. Welcomes Dr. Sonal Gupta as CMO to Revolutionize Cancer Treatment

Updated Category News Views 232

CoRegen, Inc. Welcomes Dr. Sonal Gupta as Chief Medical Officer CoRegen, a progressive biopharmaceutical company known for tackling some of the toughest cancer types, proudly shares the appointment of Sonal Gupta, M.D., Ph.D., as its Chief Medical Officer (CMO). With a focus on revolutionizing treatment methods, Dr. Gupta's role will be pivotal in implementing advanced...

Continue Reading
Understanding Coupang's Recent Short Interest Trends

Updated Category News Views 86

Analyzing Recent Trends in Coupang's Short Interest Coupang (CPNG) has recently seen a notable reduction in its short interest. Specifically, the short percent of float has dropped by 11.11% since the last reporting period. Currently, there are 14.30 million shares sold short, which constitutes 1.44% of the total regular shares available for trading. Based on the...

Continue Reading
Saia Reports LTL Shipment Insights and Trends for Second Quarter

Updated Category News Views 177

Understanding Saia's LTL Shipment Performance Saia, Inc. (NASDAQ: SAIA), an established leader in the transportation sector, has released intriguing data regarding their less-than-truckload (LTL) services for the second quarter. The company's reports indicate a nuanced but telling shift in operations, highlighting how market dynamics are playing a role in their shipment...

Continue Reading
Insider Selling Trend: Randall K Fields Moves $159K in Stock

Updated Category News Views 428

Randall K Fields Takes Major Step with ReposiTrak Recently, Randall K Fields, the Chief Executive Officer at ReposiTrak (TRAK), revealed plans for his stock holdings by executing a significant insider sale. This transaction, categorized in the latest SEC filing, saw Fields selling 7,500 shares valued at approximately $159,360. As the stock market changes daily, ReposiTrak...

Continue Reading